NO974811L - CNS-utvekstmodulatorer, preparater, celler og fremgangsmåter som omfatter og anvender slike - Google Patents

CNS-utvekstmodulatorer, preparater, celler og fremgangsmåter som omfatter og anvender slike

Info

Publication number
NO974811L
NO974811L NO974811A NO974811A NO974811L NO 974811 L NO974811 L NO 974811L NO 974811 A NO974811 A NO 974811A NO 974811 A NO974811 A NO 974811A NO 974811 L NO974811 L NO 974811L
Authority
NO
Norway
Prior art keywords
nerve
methods
cells
adhesion molecule
molecules
Prior art date
Application number
NO974811A
Other languages
English (en)
Other versions
NO974811D0 (no
Inventor
Melitta Schachner
Original Assignee
Acorda Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics filed Critical Acorda Therapeutics
Publication of NO974811D0 publication Critical patent/NO974811D0/no
Publication of NO974811L publication Critical patent/NO974811L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)

Abstract

En fremgangsmåte for å fremme nervevekst ±n vivo i pattedyrsentral-nervesystemet ved administrering av et nervecelleadhesjonsmolekyl som kan overvinne inhibitoriske molekylære stikkord funnet på gliaceller og myelin for å fremme nervevekst. Aktive frag-menter, beslektede molekyler, molekyler av samme type, etterligninger, analoger, utskillende celler og opp-løselige molekyler derav, så vel som antistoffer mot disse, og DNA-molekyler, vektorer og transformerte celler som er i stand til å uttrykke disse er også beskrevet. Transgene muselinjer som uttrykker et nerveadhesjonsmolekyl i differensierte astrocytter og celler og vev avledet fra disse er også beskrevet. Ekspresjon av nerveadhesjonsmolekylet øker neurittutvekst på sentralnervesystemvev avledet fra disse transgene mus. Fremgangsmåter for å øke neuronutvekst fra CNS-neuroner, for-bedre hukommelsen ogkning av synaptisk effektivitet er også beskrevet. Fremgangsmåter for testing av legemidler som modulerer virkningen av nerveadhesjonsmolekylet og analyse-systemer egnede for slike metoder er også beskrevet.
NO974811A 1995-04-19 1997-10-17 CNS-utvekstmodulatorer, preparater, celler og fremgangsmåter som omfatter og anvender slike NO974811L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42499595A 1995-04-19 1995-04-19
US48395995A 1995-06-07 1995-06-07
PCT/US1996/005434 WO1996032959A1 (en) 1995-04-19 1996-04-19 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same

Publications (2)

Publication Number Publication Date
NO974811D0 NO974811D0 (no) 1997-10-17
NO974811L true NO974811L (no) 1997-12-19

Family

ID=27026535

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974811A NO974811L (no) 1995-04-19 1997-10-17 CNS-utvekstmodulatorer, preparater, celler og fremgangsmåter som omfatter og anvender slike

Country Status (15)

Country Link
EP (1) EP0821591A1 (no)
JP (1) JPH11504211A (no)
KR (1) KR19990007893A (no)
AU (1) AU718508B2 (no)
CA (1) CA2218599A1 (no)
CZ (1) CZ330197A3 (no)
EA (1) EA199700323A1 (no)
HU (1) HUP9900060A3 (no)
IS (1) IS4590A (no)
MX (1) MX9708127A (no)
NO (1) NO974811L (no)
PL (1) PL322947A1 (no)
SK (1) SK142497A3 (no)
TR (2) TR199801650T2 (no)
WO (1) WO1996032959A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2190418A1 (en) * 1996-11-15 1998-05-15 Zhi-Cheng Xiao Neuron and neural tumor growth regulatory system, antibodies thereto and uses thereof
EP0910641A1 (en) * 1997-02-13 1999-04-28 Smithkline Beecham Plc Neural cell adhesion molecule splicing variants
WO2000018801A2 (en) * 1998-09-29 2000-04-06 Roenn Lars Christian B Ncam binding compounds
AUPQ614200A0 (en) * 2000-03-10 2000-03-30 Department Of Human Physiology, Flinders University School Of Medicine Method for treating chronic spinal cord injury
JP2004505609A (ja) * 2000-04-03 2004-02-26 オックスフォード　グリコサイエンシズ（ユーケー）　リミテッド 核酸分子、ポリペプチド、ならびにアルツハイマー病の診断および処置を含むそれらの使用
EP1408333A3 (en) * 2001-10-03 2006-10-25 Pfizer Products Inc. Diagnosis and treatment of Alzheimer's disease
AR040778A1 (es) 2002-08-06 2005-04-20 Glaxo Group Ltd Anticuerpos alterados o fragmentos funcionales que se unen a mag (glicoproteina asociada a mielina).
WO2004016733A2 (en) 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
WO2011017605A2 (en) 2009-08-07 2011-02-10 Affinimark Technologies, Inc. Device and methods for the immunological identification of cerebrospinal fluid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE124726T1 (de) * 1988-11-04 1995-07-15 Zuerich Erziehungsdirektion Wachstumsregelfaktoren für neuriten.
WO1993000427A2 (en) * 1991-06-24 1993-01-07 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
JPH09511219A (ja) * 1993-11-08 1997-11-11 ニュー ヨーク ユニバーシティ 神経損傷の治療における神経細胞−グリア細胞間接着分子Ｎｇ−ＣＡＭ

Also Published As

Publication number Publication date
TR199701203T1 (en) 1998-03-21
CZ330197A3 (cs) 1998-04-15
EP0821591A1 (en) 1998-02-04
CA2218599A1 (en) 1996-10-24
TR199801650T2 (en) 1999-03-22
MX9708127A (es) 1998-06-28
WO1996032959A1 (en) 1996-10-24
AU5557296A (en) 1996-11-07
HUP9900060A2 (hu) 1999-04-28
PL322947A1 (en) 1998-03-02
HUP9900060A3 (en) 2001-08-28
NO974811D0 (no) 1997-10-17
EA199700323A1 (ru) 1998-04-30
AU718508B2 (en) 2000-04-13
KR19990007893A (ko) 1999-01-25
IS4590A (is) 1997-10-15
JPH11504211A (ja) 1999-04-20
SK142497A3 (en) 1999-08-06

Similar Documents

Publication Publication Date Title
Schmid The mechanism of receptor‐mediated endocytosis: More questions than answers
Simova et al. Carbohydrate mimics promote functional recovery after peripheral nerve repair
NO974811L (no) CNS-utvekstmodulatorer, preparater, celler og fremgangsmåter som omfatter og anvender slike
Hartmann et al. Formation of specific amino acid sequences during thermal polymerization of amino acids
DE69634043D1 (de) Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie
Willard et al. Molecular events in axonal regeneration
Grimmelikhuijzen et al. Coelenterate neuropeptides: structure, action and biosynthesis
PL334530A1 (en) Novel genes specific in respect to n-axecetyl-l-phosphotricin, used to code amino acids deacetylase, their isolation and application
ATE348175T1 (de) Method eder intrazellularen bindung von zielgerichteten molekülen
DE59611371D1 (de) Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen
Lim et al. Human induced pluripotent stem cell derived neural stem cell survival and neural differentiation on polyethylene glycol dimethacrylate hydrogels containing a continuous concentration gradient of N-Cadherin derived peptide His-Ala-Val-Asp-Ile
WO1999009057A3 (en) Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns
ATE242316T1 (de) Neurale transplantation durch verwendung von pluripotenten neuroepithelzellen
Trevor et al. Acetylcholinesterases
Panchin et al. Lobster stomatogastric neurons in primary culture. I. Basic characteristics
Boyer Conformational coupling in oxidative phosphorylation and photophosphorylation
ZA963971B (en) A method and nucleotide sequence for transforming microorganisms
Bisby Retrograde axonal transport and nerve regeneration
Arshavsky et al. Control of feeding movements in the freshwater snail Planorbis corneus: II. Activity of isolated neurons of buccal ganglia
Grafstein et al. Role of fast axonal transport in regeneration of goldfish optic axons
Fox Thermal proteins in the first life and in the “mind-body” problem
Roubos et al. Adenylate cyclase activity in axon terminals of ovulation-hormone producing neuroendocrine cells of Lymnaea stagnalis (L.)
Beyer et al. Lymphocyte Transformation Induced by Chemical Modification of Membrane Components: II. Effect of Neuraminidase Treatment of Responder Cells on Proliferation and Cytotoxicity in Indirect Stimulation
BAXTER et al. L16, a bifunctional ribosomal protein and the enhancing effect of L6 and L11
DE69631624D1 (de) Antikörper gegen menschliches restrictin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application